Phenylbutazone use as an NSAID is restricted because :
**Core Concept**
Phenylbutazone is a potent nonsteroidal anti-inflammatory drug (NSAID) that was widely used in the past for its anti-inflammatory and analgesic properties. However, its use is now restricted due to its potential for serious side effects, particularly bone marrow suppression.
**Why the Correct Answer is Right**
Phenylbutazone is a propionic acid derivative NSAID that works by inhibiting cyclooxygenase (COX) enzymes, which are responsible for the production of prostaglandins. Prostaglandins play a key role in inflammation and pain. However, phenylbutazone also has a unique mechanism of action, which involves the inhibition of bone marrow cell production, leading to aplastic anemia and agranulocytosis. This rare but potentially fatal side effect has led to its restricted use.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because while phenylbutazone does have gastrointestinal side effects, such as nausea and vomiting, these are not the primary reason for its restricted use.
**Option B:** This option is incorrect because while phenylbutazone does have a potential for renal toxicity, this is not the primary reason for its restricted use.
**Option C:** This option is incorrect because while phenylbutazone does have a potential for hepatotoxicity, this is not the primary reason for its restricted use.
**Clinical Pearl / High-Yield Fact**
It's essential to remember that phenylbutazone is a high-risk medication that should only be used in life-threatening situations, such as severe rheumatoid arthritis or ankylosing spondylitis, and under close monitoring by a healthcare provider.
**Correct Answer: C. Its potential for bone marrow suppression.**